Page 178 - Read Online

8. Coyle CM, Tanowitz HB. Diagnosis and treatment of 2004;19:482‑92.
neurocysticercosis. Interdiscip Perspect Infect Dis 2009;2009:180742. 20. Gauchan E, Malla T, Basnet S, Rao KS. Variability of presentations
9. Del Brutto OH. Diagnostic criteria for neurocysticercosis, revisited. and CT‑scan findings in children with neurocysticercosis. Kathmandu
Pathog Glob Health 2012;106:299‑304. Univ Med J (KUMJ) 2011;9:17‑21.
10. Rajshekhar V, Joshi DD, Doanh NQ, van De N, Xiaonong Z. Taenia 21. Basu S, Ramchandran U, Thapliya A. Clinical profile and outcome
solium taeniosis/cysticercosis in Asia: epidemiology, impact and of pediatric neurocysticercosis: a study from Western Nepal. J Pediatr
issues. Acta Trop 2003;87:53‑60. Neurol 2007;1:45‑52.
11. Del Brutto OH, García HH. Neurocysticercosis in nonendemic 22. Nash T. Edema surrounding calcified intracranial cysticerci: clinical
countries: time for a reappraisal. Neuroepidemiology 2012;39:145‑6. manifestations, natural history, and treatment. Pathog Glob Health
12. Chaoshuang L, Zhixin Z, Xiaohong W, Zhanlian H, Zhiliang G. 2012;106:275‑9.
Clinical analysis of 52 cases of neurocysticercosis. Trop Doct 23. Lucato LT, Guedes MS, Sato JR, Bacheschi LA, Machado LR,
2008;38:192‑4. Leite CC. The role of conventional MR imaging sequences in
13. das Chagas Md, D’Oliveira Júnior A, Tavares‑Neto J. Clinical aspects the evaluation of neurocysticercosis: impact on characterization
of neurocysticercosis at semi‑desert region of Brazilian northeast. of the scolex and lesion burden. AJNR Am J Neuroradiol
Arq Neuropsiquiatr 2003;61:398‑402. 2007;28:1501‑4.
14. Benedeti MR, Falavigna DL, Falavigna‑Guilherme AL, Araújo SM. 24. Del Brutto OH, Santibañez R, Noboa CA, Aguirre R, Díaz E, Alarcón
Epidemiological and clinical profile of neurocysticercosis patients TA. Epilepsy due to neurocysticercosis: analysis of 203 patients.
assisted by the Hospital Universitário Regional de Maringá, Paraná, Neurology 1992;42:389‑92.
Brazil. Arq Neuropsiquiatr 2007;65:124‑9. 25. Morales NM, Agapejev S, Morales RR, Padula NA, Lima MM.
15. Rajshekhar V, Raghava MV, Prabhakaran V, Oommen A, Muliyil J. Clinical aspects of neurocysticercosis in children. Pediatr Neurol
Active epilepsy as an index of burden of neurocysticercosis in Vellore 2000;22:287‑91.
district, India. Neurology 2006;67:2135‑9. 26. Talukdar B, Saxena A, Popli VK, Choudhury V. Neurocysticercosis
16. Singhi P, Ray M, Singhi S, Khandelwal N. Clinical spectrum of in children: clinical characteristics and outcome. Ann Trop Paediatr
500 children with neurocysticercosis and response to albendazole 2002;22:333‑9.
therapy. J Child Neurol 2000;15:207‑13.
17. Morgado C, Gomes LB, de Campos JG. Neurocysticercosis. An
imaging analysis of 35 cases. Acta Med Port 1994;7:269‑75. Cite this article as: Ojha R, Shah DB, Shrestha A, Koirala S, Dahal A,
18. Bhattacharjee S, Biswas P, Mondal T. Clinical profile and follow‑up Adhikari K, Bisht A, Wagle P. Neurocysticercosis in Nepal: a retrospective
clinical analysis. Neuroimmunol Neuroinflammation 2015;2(3):167-70.
of 51 pediatric neurocysticercosis cases: a study from Eastern India. Source of Support: Nil. Conflict of Interest: No.
Ann Indian Acad Neurol 2013;16:549‑55.
19. Singhi P, Singhi S. Neurocysticercosis in children. J Child Neurol Received: 12-11-2014; Accepted: 19-02-2015

170 Neuroimmunol Neuroinflammation | Volume 2 | Issue 3 | July 15, 2015 Neuroimmunol Neuroinflammation | Volume 2 | Issue 3 | July 15, 2015 PB